Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Equity (2021 - 2025)

Historic Return on Equity for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to 0.3%.

  • Arcutis Biotherapeutics' Return on Equity rose 8400.0% to 0.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 8400.0%. This contributed to the annual value of 1.14% for FY2024, which is 6200.0% up from last year.
  • Per Arcutis Biotherapeutics' latest filing, its Return on Equity stood at 0.3% for Q3 2025, which was up 8400.0% from 0.66% recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Return on Equity ranged from a high of 0.1% in Q1 2021 and a low of 4.21% during Q3 2023
  • Over the past 5 years, Arcutis Biotherapeutics' median Return on Equity value was 0.97% (recorded in 2024), while the average stood at 1.32%.
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Return on Equity crashed by -28800bps in 2023, and later skyrocketed by 30700bps in 2024.
  • Over the past 5 years, Arcutis Biotherapeutics' Return on Equity (Quarter) stood at 0.63% in 2021, then crashed by -108bps to 1.3% in 2022, then plummeted by -198bps to 3.87% in 2023, then skyrocketed by 77bps to 0.89% in 2024, then skyrocketed by 67bps to 0.3% in 2025.
  • Its Return on Equity stands at 0.3% for Q3 2025, versus 0.66% for Q2 2025 and 0.86% for Q1 2025.